| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.46▲ | 1.46▲ | 1.47▼ | 1.42▲ | 1.57▼ |
| MA10 | 1.46▼ | 1.46▲ | 1.45▲ | 1.43▲ | 1.54▼ |
| MA20 | 1.44▲ | 1.43▲ | 1.43▲ | 1.56▼ | 1.61▼ |
| MA50 | 1.42▲ | 1.43▲ | 1.43▲ | 1.53▼ | 1.90▼ |
| MA100 | 1.43▲ | 1.51▼ | 1.57▼ | 1.63▼ | 1.22▲ |
| MA200 | 1.54▼ | 1.56▼ | 1.55▼ | 1.83▼ | 1.36▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.005▲ | 0.006▲ | -0.015▼ | -0.012▼ |
| RSI | 58.264▲ | 56.399▲ | 54.449▲ | 43.276▼ | 44.454▼ |
| STOCH | 67.121 | 76.076 | 85.360▲ | 36.978 | 39.648 |
| WILL %R | -33.333 | -23.529▲ | -23.529▲ | -79.926▼ | -85.000▼ |
| CCI | 34.619 | 71.429 | 76.094 | -33.609 | -73.148 |
|
Sunday, June 14, 2026 05:00 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
|
Thursday, April 02, 2026 05:01 PM
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE)-- IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative γδ T cell therapies for cancer and autoimmune ...
|
|
Thursday, February 19, 2026 04:00 PM
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/06/26 | 1.43 | 1.485 | 1.43 | 1.43 | 45,615 |
| 17/06/26 | 1.40 | 1.47 | 1.40 | 1.47 | 22,545 |
| 16/06/26 | 1.4346 | 1.4346 | 1.38 | 1.38 | 40,399 |
| 15/06/26 | 1.45 | 1.458 | 1.39 | 1.39 | 30,532 |
| 12/06/26 | 1.41 | 1.46 | 1.41 | 1.43 | 11,073 |
| 11/06/26 | 1.38 | 1.44 | 1.322 | 1.44 | 57,869 |
| 10/06/26 | 1.4101 | 1.4995 | 1.3751 | 1.40 | 37,661 |
| 09/06/26 | 1.40 | 1.49 | 1.40 | 1.45 | 34,244 |
| 08/06/26 | 1.49 | 1.4999 | 1.41 | 1.44 | 25,823 |
| 05/06/26 | 1.56 | 1.565 | 1.4251 | 1.45 | 71,407 |
|
|
||||
|
|
||||
|
|